DavidSikes

Partner

(T) + 1.650.687.4192

Connect:

Share

David Sikes has more than 15 years of experience in advising clients in the areas of mergers and acquisitions, corporate governance, and venture capital transactions. He focuses his practice on the representation of technology and life sciences clients. As an active and engaged participant in the Silicon Valley legal community, David has a deep understanding of the legal issues facing cutting-edge companies and their acquirors.

He has counseled acquirors and sellers in a variety of M&A transactions (including some of the technology industry's most significant recent deals) in both private and public contexts, including mergers, tender offers, stock and asset acquisitions, and distressed companies. His corporate governance experience includes '34 Act filings and general corporate advice. His capital markets experience includes private company equity and debt transactions and public company equity and convertible debt issuances. David advises on venture capital financings, primarily involving acquisitions of preferred stock or convertible debt, and counsels early-stage issuers in the areas of formation and financing.

David is a past member of the Corporations Committee of the Business Law Section of the State Bar of California, for which he previously served as vice chair of communications, and is a frequent speaker for Financial Poise.

Experience

  • Western Digital acquires Kazan NetworksJones Day advised Western Digital Corporation (NASDAQ:WDC) in its acquisition of Kazan Networks Corp., a provider of industry leading NVMe™-over-Fabric (NVMe-oF) ASIC and adapter products for next-generation data center architectures.
  • Huadong Medicine invests in R2 Dermatology and enters into distribution agreementJones Day advised Huadong Medicine Co. Ltd., a Chinese manufacturer and distributor of pharmaceutical and other medical products, in connection with its subscription of Series B Preferred Shares of R2 Dermatology, Inc., and the negotiation of a distribution agreement authorizing Huadong Medicine as an exclusive distributor in Asia for R2's skin whitening products.
  • Alven Capital, Index Ventures, Via-ID, and Bpifrance sell European platform Drivy to Getaround for $300 millionJones Day advised majority investor sellers (Alven Capital, Index Ventures, Via-ID, and Bpifrance) of Drivy, peer-to-peer car-sharing leader in Europe, in connection with its sale to Getaround for $300 million.
  • Lam Research completes $2.5 billion public offering of Senior NotesJones Day advised Lam Research Corporation, a global supplier of wafer fabrication equipment and services to the worldwide semiconductor industry, in connection with its underwritten public offering of $2.5 billion of Senior Notes, consisting of $750 million of 3.750% Senior Notes due 2026, $1.0 billion of 4.000% Senior Notes due 2029, and $750 million of 4.875% Senior Notes due 2049.
  • Cylance acquired by BlackBerry for $1.4 billionJones Day advised Cylance, an artificial intelligence and cybersecurity leader, in its $1.4 billion acquisition by BlackBerry Limited, plus the assumption of unvested employee incentive awards.
  • Smith & Nephew acquires Ceterix® Orthopaedics Inc. for up to $105 millionJones Day advised Smith & Nephew in its acquisition of Ceterix® Orthopaedics, Inc., the developer of a unique device that addresses complex meniscal tear patterns, for up to $105 million.
  • Seventure and CM-CIC Capital Privé sell majority stake in Presto Engineering to NewAlpha Asset ManagementJones Day represented Seventure Partners and CM-CIC Capital Privé in connection with the sale of a majority stake in Presto Engineering, a provider of industrialization and semiconductor manufacturing solutions in the industrial sector, to NewAlpha Asset Management.
  • Hitachi Vantara acquires REAN CloudJones Day advised Hitachi Vantara in its acquisition of REAN Cloud LLC, a global cloud systems integrator, managed services provider and solutions developer of cloud-native applications across big data, machine learning and emerging internet of things (IoT) spaces.
  • Rgenix raises capital in Series C roundJones Day represented Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, in connection with its issuance of $40 million of Series C Convertible Preferred Stock in a private placement to Lepu Medical, Oceanpine Capital and WuXi AppTec’s Corporate Venture Fund, Novo Holdings A/S, Sofinnova Partners, Alexandria Venture Investments, LLC, and the Partnership Fund for New York City’s Innovate NY Fund and associated entities.
  • LumaSense acquired by Advanced EnergyJones Day advised LumaSense Technologies Holdings, Inc. in its acquisition by Advanced Energy Industries, Inc.
  • Next Insurance raises $83 million in Series B roundJones Day represented Next Insurance, Inc., an online insurance company for entrepreneurs and small businesses, in connection with its sale of $83 million of Series B Convertible Preferred Stock in a private placement led by to Redpoint Ventures.
  • Partech Partners invests in TradeDepotJones Day represented Partech Partners in connection with its purchase of Series A Convertible Preferred Stock in a private placement by TradeDepot, the innovative SaaS platform for FMCG distribution in Africa.
  • SAP acquires GigyaJones Day advised SAP SE in its acquisition of Gigya, Inc., a market leader for customer identity and access management.
  • Ivalua acquires DirectworksJones Day advised Ivalua, a global provider of spend management solutions assisting clients in procurement, sourcing, and supplier risk management, in its acquisition of Directworks, a Pittsburgh-based developer of cloud-based logistics management software.
  • Lam Research acquires Coventor, Inc.Jones Day advised Lam Research Corporation in its acquisition of Coventor, Inc., a leading provider of simulation and modeling solutions for semiconductor process technology, micro-electromechanical systems (MEMS), and the Internet of Things (IoT).
  • KKR invests in ForgeRockJones Day represented Kohlberg Kravis Roberts & Co. L.P. in connection with its Series D funding round by ForgeRock, a multinational identity and access management software company.
  • Adams Street invests in LeverJones Day represented Adams Street Partners in connection with its purchase of Series C Convertible Preferred Stock in a private placement by Lever, Inc., a human resources/recruiting software company.
  • Adams Street further invests in SmuleJones Day represented Adams Street Partners in connection with its investment in Smule, Inc., a social network for musical performance powered by a family of award winning mobile applications.
  • ETS acquires Questar Assessment Inc. for $127.5 millionJones Day advised Educational Testing Service in its $127.5 million cash acquisition of Questar Assessment Inc., a leading K–12 assessment solutions provider focused on building a bridge between learning and accountability.
  • Intersil acquired by Renesas Electronics for $3.2 billionJones Day advised Intersil Corporation, a provider of power management and precision analog solutions, in its $3.2 billion acquisition by Renesas Electronics Corporation, a supplier of advanced semiconductor solutions.
    • View All

    October 2018 Commentaries

    California Mandates Female Directors for Public Corporations

    November 2017 White Paper

    Legal Issues Related to the Development of Automated, Autonomous, and Connected Cars

    Speaking Engagements

    • April 5, 2017
      Common Deal Points: FinancialPoie/West LegalEdcenter
    • April 27, 2016
      M&A Private Company Bootcamp 2016 - Special Issues in Special Transactions: FinancialPoise/West LegalEdcenter
    • March 10, 2015
      Structuring and Planning the Transaction, FinancialPoise/West LegalEdcenter
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.